UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001626
Receipt number R000001954
Scientific Title Neoadjuvant chemoradiotherapy followed by esophagectomy for REG I positive T4, N4 or many thoracic esophageal cancer
Date of disclosure of the study information 2009/01/07
Last modified on 2019/09/19 16:32:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Neoadjuvant chemoradiotherapy followed by esophagectomy for REG I positive T4, N4 or many thoracic esophageal cancer

Acronym

Neoadjuvant chemoradiotherapy followed by esophagectomy for REG I positive T4, N4 or many thoracic esophageal cancer

Scientific Title

Neoadjuvant chemoradiotherapy followed by esophagectomy for REG I positive T4, N4 or many thoracic esophageal cancer

Scientific Title:Acronym

Neoadjuvant chemoradiotherapy followed by esophagectomy for REG I positive T4, N4 or many thoracic esophageal cancer

Region

Japan


Condition

Condition

thoracic esophageal cancer

Classification by specialty

Gastroenterology Gastrointestinal surgery Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To test that patients with T4 or N-many thoracic esophageal cancer expressing REG I in untreated endoscopic biopsy specimens achieved long-term survival when treated with neoadjuvant CRT followed by esophagectomy.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Phase II


Assessment

Primary outcomes

overall survival

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

esophagectomy with lymph nodes dissection

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) primary squamous cell carcinoma of thoracic esophagus
(2) clinical-T4, clinical-N4 or N-many
(3) ECOG-PS 0,1,2
(4) resectable esophageal cancer
(5) Cr<1.2 mg/dl, BUN<25 mg/dl, 24h CCr>60 ml/min, T.Bil<1.2 mg/dl, GOT and GPT<100 IU, WBC>4,000 /mm3, Hb>10 g/dl, Plt>100,000 /mm3, PaO2>70 torr

Key exclusion criteria

(1) treatment history of chemotherapy or radiotherapy

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Satoru
Middle name
Last name Motoyama

Organization

Akita University School of Medicine

Division name

Department of Surgery

Zip code

0108543

Address

1-1-1 Hondo, Akita

TEL

018-884-6132

Email

motoyama@doc.med.akita-u.ac.jp


Public contact

Name of contact person

1st name Satoru
Middle name
Last name Motoyama

Organization

Akita University School of Medicine

Division name

Department of General Affairs

Zip code

0108643

Address

1-1-1 Hondo, Akita

TEL

018-834-1111

Homepage URL


Email

soumu@hos.akita-u.ac.jp


Sponsor or person

Institute

The Cancer Board of Esophageal Cancer in Akita University Hospital

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Akita University School of Medicine

Address

1-1-1 Hondo, Akita

Tel

018-834-1111

Email

soumu@hos.akita-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 01 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2008 Year 11 Month 28 Day

Date of IRB


Anticipated trial start date

2009 Year 01 Month 01 Day

Last follow-up date

2011 Year 12 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2009 Year 01 Month 07 Day

Last modified on

2019 Year 09 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001954


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name